ReviewCureus2025
Global Prevalence, Regional Distribution, and Demographic Patterns of Schistosomal Appendicitis: A Systematic Review and Meta-Analysis.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The prevalence of schistosomal appendicitis (SA) remains uncertain due to its infrequent occurrence in medical practice. This systematic review and meta-analysis aimed to determine the global prevalence and distribution patterns of SA. Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, five databases were searched up to June 2025. Eligible studies were observational cohorts reporting histologically confirmed cases of SA from appendectomy specimens. Two independent reviewers conducted data extraction, and study quality was assessed using the Joanna Briggs Institute (JBI) checklist for prevalence studies. A random-effects meta-analysis was performed to estimate pooled prevalence, with subgroup analyses by endemicity, region, income level, and study period. Twenty-four studies comprising 41,301 appendectomy specimens were included. The global pooled prevalence of SA was 1.84% (95% CI: 1.13%-2.71%). Prevalence was higher in endemic regions (2.67%, 95% CI: 1.81%-3.69%) than in non-endemic regions (0.16%, 95% CI: 0.10%-0.24%). Lower-middle-income countries had the highest prevalence (2.66%, 95% CI: 1.94%-3.47%), followed by upper-middle-income (2.10%, 95% CI: 0.55%-4.58%) and high-income countries (0.59%, 95% CI: 0.24%-1.08%). Regionally, Africa had the highest pooled prevalence (3.22%, 95% CI: 1.69%-5.18%), followed by Asia (1.01%, 95% CI: 0.39%-1.91%). Among 247 histologically confirmed cases, 91.92% (95% CI: 76.22%-100.00%) showed appendiceal inflammation. A temporal trend indicated rising SA prevalence after 2015, and a male predominance was noted, with a male-to-female ratio of 2.78:1. Heterogeneity among studies was high (I² = 96.7%), and funnel plot analysis suggested potential publication bias. Despite declining global incidence, SA remains a significant cause of appendicitis in endemic areas. Routine histopathological examination of appendectomy specimens is recommended, alongside sustained control and elimination efforts to reduce disease burden.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.